Abstract
Excessive sympathetic activity and stress-induced left ventricular (LV) hypercontractility have been described in hypertensive LV hypertrophy. Recent quantitative data have shown that hypertensive LV hypertrophy is associated with preserved global LV function. However, progression of uncontrolled hypertension have detrimental effects on both the ejection fraction (EF) and LV contractile response to stress. Hypertensive LV hypertrophy has some common characteristics, including preserved global LV systolic function and LV volume with heart failure with preserved EF (HFPEF), which makes it difficult to differentiate between the two conditions at rest. Studies suggest that adopting an efficient antihypertensive therapy regimen may positively effect on the LV contractile capability in patients with long-standing hypertension. Evaluation of quantitative LV contractility under stress may be beneficial to differentiate between the hypertensive LV hypertrophy and HFPEF. It may also assist in developing a more effective modality in medical management of patients with hypertensive heart disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gottdiener JS, Brown J, Zoltick J, Fletcher RD . Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise. Ann Intern Med 1990; 112: 161–166.
Lauer MS, Levy D, Anderson KM, Plehn JF . Is there a relationship between exercise systolic blood pressure response and left ventricular mass: The Framingham Heart study. Ann Intern Med 1992; 116: 203–210.
Dlin RA, Hanne N, Silverberg DS, Bar-Or O . Follow-up of normotensive men with exaggerated blood pressure response to exercise. Am Heart J 1983; 106: 316–320.
Landry F, Jette M, Blumchen G . Exercise hypertension in the perspective of systemic arterial hypertension. Herz 1987; 12: 75–82.
Papademetriou V . Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events. Am Heart J 2009; 157: S24–S30.
Gradman AH, Papademetriou V . Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction. Am Heart J 2009; 157: S17–S23.
de Simone G, Di Lorenzo L, Costantino G, Moccia D, Buonissimo S, de Divitiis O . Supernormal contractility in primary hypertension without left ventricular hypertrophy. Hypertension 1988; 11: 457–463.
Lutas EM, Devereux RB, Reis G, Alderman MH, Pickering TG, Borer JS et al. Increased cardiac performance in mild essential hypertension. Left ventricular mechanics. Hypertension 1985; 7: 979–988.
Hinderliter AL, Light KC, Willis PW . Patients with borderline elevated blood pressure have enhanced left ventricular contractility. Am J Hypertens 1995; 8: 1040–1045.
Golbasi Z, Sakalli M, Cicek D, Aydogdu S . Dynamic left ventricular outflow tract obstruction in a patient with pheochromocytoma. Jpn Heart J 1999; 40: 831–835.
Come PC, Bulkley BH, Goodman ZD, Hutchins GM, Pitt B, Fortuin NJ . Hypercontractile cardiac states stimulating hypertrophic cardiomyopathy. Circulation 1977; 55: 901–908.
Madaric J, Bartunek J, Verhamme K, Penicka M, Van Schuerbeeck E, Nellens P et al. Hyperdynamic myocardial response to beta-adrenergic stimulation in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 2005; 46: 1270–1275.
Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD . Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003; 108: 560–565.
Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS et al. The prevalance and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7: 639–650.
Papademetriou V, Gottdiener JS, Fletcher RD, Freis ED . Echocardiographic assessment by computer assisted analysis of diastolic left ventricular function and left ventricular hypertrophy borderline or mild systemic hypertension. Am J Cardiol 1985; 56: 546–550.
de Simone G, Devereux RB, Kimball TR, Mureddu GF, Roman MJ et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 1998; 31: 1077–1082.
Piccirillo G, Bucca C, Tarantini S, Santagada E, Viola E, Durante M et al. Left ventricular mass and heart rate variability in middle-aged and elderly salt-sensitive hypertensive subjects. Arch Gerontol Geriatr 1999; 28: 159–177.
Frielingsdorf J, Franke A, Kühl HP, Hess OM, Flachskampf FA . Evaluation of septal hypertrophy and systolic function in diseases that cause left ventricular hypertrophy: a 3-dimensional echocardiography study. J Am Soc Echocardiogr 2001; 14: 370–377.
Krasnow N . Subaortic septal bulge simulates hypertrophic cardiomyopathy by angulation of the septum with age, independent of focal hypertrophy. An echocardiographic study. J Am Soc Echocardiogr 1997; 10: 545–555.
Yalçin F, Muderrisoglu H, Korkmaz ME, Ozin B, Baltali M, Yigit F . The effect of dobutamine stress on left ventricular outflow tract gradients in hypertensive patients with basal septal hypertrophy. Angiology 2004; 55: 295–301.
Ieki K, Imataka K, Sakurai S, Okamoto E, Ashida T, Fujii J . Differentiation of hypertrophic cardiomyopathy and hypertensive cardiac hypertrophy using the patterns of interventricular hypertrophy. J Cardiol 1996; 27: 309–314.
Yalçin F, Muderrisoglu H . Takotsubo cardiomyopathy may be associated with cardiac geometric features as observed in hypertensive heart disease. Int J Cardiol 2009; 135: 251–252.
Vieira ML, Silva Filho RM, Brito Filho FS, Leal SB, Lira Filho EB, Fischer CH et al. Selective contrast echocardiography in percutaneous transluminal septal myocardial ablation in an elderly patient with left ventricular concentric hypertrophy. Echocardiography 2003; 20: 563–566.
Yalçin F, Shiota T, Odabashian J . Comparison by real-time three-dimensional echocardiography of left ventricular geometry in hypertrophic cardiomyopathy versus secondary left ventricular hypertrophy. Am J Cardiol 2000; 85: 1035–1038.
Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH . Left ventricular fibre architecture in man. Br Heart J 1981; 45: 248–263.
Caselli S, Pelliccia A, Maron M, Santini D, Puccio D, Marcantonio A et al. Differentiation of hypertrophic cardiomyopathy from other forms of left ventricular hypertrophy by means of three-dimensional echocardiography. Am J Cardiol 2008; 102: 616–620.
Pierpont GL, DcMastcr EG, Cohn JN . Regional differences in adrenergic function within the left ventricle. Am J Physiol 1984; 246: 824–829.
Angelakos ET . Regional distribution of catecholamines in dog heart. Circ Res 1965; 16: 39–44.
Chilian AW, Boatwright RB, Shoji T, Griggs Jr DM . Regional uptake of H-norepinephrine by the canine left ventricle. Proc Sec Exp Biol Med 1982; 171: 158–163.
Pierpont GL, DeMaster EG, Cohn JN . Regional differences in adrenergic function within the left ventricle. Am J Physiol 1983; 244: 607–613.
Mori H, Ishikawa S, Kojima S, Hayashi J, Watanabe Y, Hoffman JI et al. Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc Res 1993; 27: 192–198.
Yalçin F, Yigit F, Erol T, Baltali M, Korkmaz ME, Müderrisoglu H . Effect of dobutamine stress on basal septal tissue dynamics in hypertensive patients with basal septal hypertrophy. J Hum Hypertens 2006; 20: 628–630.
Akers WS, Cross A, Speth R, Dwoskin LP, Cassis LA . Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy. Am J Physiol Heart Circ Physiol 2000; 279: 2797–2806.
Nakagawa M, Sano N, Nobe S, Ichinose M, Yonemochi H, Saikawa T . Patients with mild hypertensive heart disease and left ventricular outflow tract obstruction: treatment with angiotensin II antagonists. Heart Vessels 2004; 19: 248–251.
Al-Nasser F, Duncan A, Sharma R, O'Sullivan C, Coats AJ, Anker SD et al. Beta-blocker therapy for dynamic left-ventricular outflow tract obstruction. Int J Cardiol 2002; 86: 199–205.
Sherrid MV, Pearle G, Gunsburg DZ . Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. Circulation 1998; 97: 41–47.
Secknus MA, Niedermaier ON, Lauer MS, Marwick TH . Diagnostic and prognostic implications of left ventricular cavity obliteration response to dobutamine echocardiography. Am J Cardiol 1998; 81: 1318–1322.
Elhendy A, Modesto KM, Mahoney DW, Khandheria BK, Seward JB, Pellikka PA . Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J Am Coll Cardiol 2003; 41: 129–135.
de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH . Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996; 93: 259–265.
Wachtell K, Gerdts E, Palmieri V, Olsen MH, Nieminen MS, Papademetriou V et al. In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. J Hypertens 2010; 28: 1541–1546.
Elhendy A, Schinkel AF, Van Domburg RT, Bax JJ, Poldermans D . Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99 m tetrofosmin myocardial perfusion imaging. J Hypertens 2003; 21: 1945.
Bigi R, Bestetti A, Strinchini A, Conte A, Gregori D, Brusoni B et al. Combined assessment of left ventricular perfusion and function by gated single-photon emission computed tomography for the risk stratification of high-risk hypertensive patients. J Hypertens 2006; 24: 767.
Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE . A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003; 115: 41–46.
Núñez J, Zamorano JL, Pérez De Isla L, Palomeque C, Almería C, Rodrigo JL et al. Differences in regional systolic and diastolic function by Doppler tissue imaging in patients with hypertrophic cardiomyopathy and hypertrophy caused by hypertension. J Am Soc Echocardiogr 2004; 17: 717–722.
Yalçin F, Shiota M, Greenberg N, Thomas JD, Shiota T . Real time three-dimensional echocardiography evaluation of mitral annular characteristics in patients with myocardial hypertrophy. Echocardiography 2008; 25: 424–428.
Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Tamaki Y et al. Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure. Circ Heart Fail 2010; 3: 420–430.
Maurer MS, King DL, El-Khoury Rumbarger L, Packer M, Burkhoff D . Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail 2005; 11: 177–187.
Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H et al. Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 2007; 115: 593–599.
Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE . Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88: 993–1003.
Weber KT, Brilla CG, Janicki JS . Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993; 27: 341–348.
Tan YT, Wenzelburger F, Lee E, Heatlie G, Frenneaux M, Sanderson JE . Abnormal left ventricular function occurs on exercise in well-treated hypertensive subjects with normal resting echocardiography. Heart 2010; 96: 948–955.
González A, López B, Ravassa S, Querejeta R, Larman M, Díez J et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension 2002; 39: 75–80.
López B, Querejeta R, Varo N, González A, Larman M, Martínez Ubago JL et al. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 2001; 104: 286–291.
Melenovsky V, Borlaug BA, Rosen B, Hay I, Ferruci L, Morell CH et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community. J Am Coll Cardiol 2007; 49: 198–207.
Diez J, Frohlich ED . A translational approach to hypertensive heart disease. Hypertension 2010; 55: 1–8.
Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SW . Progression of systolic abnormalities in patients with ‘isolated’ diastolic heart failure and diastolic dysfunction. Circulation 2002; 105: 1195–1201.
Zile MR, LeWinter MM . Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction. J Am Coll Cardiol 2007; 49: 982–985.
Yalçin F, Yalçin H, Seyfeli E, Akgul F . Stress-induced hypercontractility in patients with hypertension: an interesting imaging finding. Int J Cardiol 2009; 143 (1): e1–e3.
Borlaug BA, Lam CS, Olson TP . Cardiovascular reserve function in heart failure with preserved ejection fraction: systolic versus diastolic determinants. Circulation 2008; 118: S_1022.
Tan YT, Wenzelburger F, Lee E, Heatlie G, Leyva F, Patel K et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol 2009; 54: 36–46.
Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT et al. Systolic and diastolic heart failure in the community. JAMA 2006; 296: 2209–2216.
Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, I-PRESERVE Investigators et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008; 359: 2456–2467.
Acknowledgements
FY is supported by American Government Fulbright Scholarship. He has accepted only research equipment support from Novartis Pharmaceuticals.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Yalçin, F., Yalçin, H., Küçükler, N. et al. Quantitative left ventricular contractility analysis under stress: a new practical approach in follow-up of hypertensive patients. J Hum Hypertens 25, 578–584 (2011). https://doi.org/10.1038/jhh.2010.101
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2010.101